GE Aerospace Is Making a $12 Billion Acquisition. Here's What Investors Should Know.

GE Aerospace agreed to acquire Consolidated Precision Products for $11.75 billion, financed with $7 billion of cash and the balance with new debt, to secure a supplier that currently provides about 25% of its aerospace-casting requirements. GE expects CPP to generate roughly $2 billion in 2027 revenue and says the transaction should be accretive to adjusted EPS and free cash flow in year one, although antitrust review and increased leverage are key near-term risks. The deal targets a major production bottleneck as GE works to fulfill its approximately $210 billion backlog extending into the 2030s; shares are down more than 11% over the past month and trade near 40x forward and trailing earnings.

Analysis

The strategic value is not the acquired revenue base but the option value of converting a constrained input into controlled capacity. If vertical integration reduces engine delivery slippage, GE can recognize higher-margin original-equipment revenue sooner and, more importantly, accelerate the installed-base growth that drives long-duration aftermarket cash flow. This makes the deal potentially more valuable than a conventional cost-synergy acquisition, but only if CPP capacity is dedicated to GE rather than diluted by behavioral or regulatory supply commitments.

The principal near-term market issue is valuation versus execution: incremental debt and integration risk arrive immediately, while delivery-rate benefits will likely emerge over 12-36 months. At a premium earnings multiple, even a modest reduction in free-cash-flow conversion, leverage tolerance, or delivery guidance could produce disproportionate multiple compression. Antitrust risk is more likely to result in mandated third-party access, pricing safeguards, or supply agreements than a full block; those remedies could materially reduce the acquisition's strategic scarcity value without preventing closing.

Second-order pressure falls on engine competitors and independent casting customers if available qualified aerospace casting capacity tightens. RTX and Safran warrant monitoring for any commentary on turbine-component lead times, supplier qualification costs, or inventory builds; such signals would validate a broader supply-chain advantage for GE. Conversely, aerospace casting alternatives such as Howmet Aerospace (HWM) could gain pricing power if customers diversify away from CPP, limiting GE's ability to capture all expected procurement benefits.

Consensus appears too willing to capitalize management's first-year accretion claim before disclosure of purchase accounting, integration costs, retained customer obligations, and pro forma leverage. The better entry is likely after regulatory remedy details and initial delivery-rate evidence, not solely because of the recent share-price decline.

Key Decisions for Investors

• Maintain GE as a watch-to-buy rather than add aggressively before regulatory terms are known. Initiate only after remedies preserve meaningful internal capacity priority and management reaffirms engine-delivery and free-cash-flow guidance; target a 12-18 month horizon, with thesis invalidated by a delivery-guide cut or sustained deterioration in cash conversion.
• Use a staged long GE / short RTX pair over the next 1-3 months if supplier lead-time disclosures begin to diverge. GE should benefit from improved component control, while RTX is more exposed to industry-wide engine supply bottlenecks; size modestly because remedy-driven third-party supply requirements could erase the relative advantage.
• Monitor HWM as a second-order long candidate rather than treating it as an automatic beneficiary. Enter only if quarterly commentary shows aerospace casting pricing or new customer qualification demand; the key risk is that excess industry capacity or GE's retained CPP supply commitments prevent pricing leverage.
• For existing GE longs, define a catalyst calendar around antitrust review, financing close, and the first two post-close quarterly delivery updates. Reduce exposure if pro forma leverage, integration charges, or customer-retention obligations imply that projected accretion depends on assumptions not visible in reported free cash flow.